Which has better earnings and valuation, PDEX or INMD?

InMode has higher revenue and earnings than Pro-Dex. InMode is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pro-Dex $77.55M 2.84 $13.66M $4.13 16.66 InMode $374.63M 2.17 $93.83M $1.23 11.52

Is PDEX or INMD more profitable?

InMode has a net margin of 20.69% compared to Pro-Dex's net margin of 17.62%. Pro-Dex's return on equity of 25.13% beat InMode's return on equity. Company Net Margins Return on Equity Return on Assets Pro-Dex 17.62% 25.13% 16.02% InMode 20.69% 11.99% 10.60%

Does the media refer more to PDEX or INMD?

In the previous week, InMode had 1 more articles in the media than Pro-Dex. MarketBeat recorded 3 mentions for InMode and 2 mentions for Pro-Dex. InMode's average media sentiment score of 0.89 beat Pro-Dex's score of 0.60 indicating that InMode is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InMode 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, PDEX or SIBN?

Pro-Dex has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pro-Dex $77.55M 2.84 $13.66M $4.13 16.66 SiBone $213.60M 3.94 -$18.90M -$0.34 N/A

Is PDEX or SIBN more profitable?

Pro-Dex has a net margin of 17.62% compared to SiBone's net margin of -6.85%. Pro-Dex's return on equity of 25.13% beat SiBone's return on equity. Company Net Margins Return on Equity Return on Assets Pro-Dex 17.62% 25.13% 16.02% SiBone -6.85% -8.23% -6.07%

Does the media prefer PDEX or SIBN?

In the previous week, SiBone had 4 more articles in the media than Pro-Dex. MarketBeat recorded 6 mentions for SiBone and 2 mentions for Pro-Dex. SiBone's average media sentiment score of 0.81 beat Pro-Dex's score of 0.60 indicating that SiBone is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SiBone 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend PDEX or NNNN?

Pro-Dex presently has a consensus target price of $74.00, suggesting a potential upside of 7.53%. Given Pro-Dex's stronger consensus rating and higher possible upside, equities analysts clearly believe Pro-Dex is more favorable than Anbio Biotechnology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pro-Dex 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00 Anbio Biotechnology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, PDEX or NNNN?

Pro-Dex has higher revenue and earnings than Anbio Biotechnology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pro-Dex $77.55M 2.84 $13.66M $4.13 16.66 Anbio Biotechnology $8.65M 103.69 $6.40M N/A N/A

Does the media favor AVR or PDEX?

In the previous week, Anteris Technologies Global had 2 more articles in the media than Pro-Dex. MarketBeat recorded 4 mentions for Anteris Technologies Global and 2 mentions for Pro-Dex. Anteris Technologies Global's average media sentiment score of 0.83 beat Pro-Dex's score of 0.60 indicating that Anteris Technologies Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pro-Dex 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, VREX or PDEX?

Pro-Dex has lower revenue, but higher earnings than Varex Imaging. Pro-Dex is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Varex Imaging $865M 0.90 -$70.30M $0.52 35.51 Pro-Dex $77.55M 2.84 $13.66M $4.13 16.66

Is VREX or PDEX more profitable?

Pro-Dex has a net margin of 17.62% compared to Varex Imaging's net margin of 2.55%. Pro-Dex's return on equity of 25.13% beat Varex Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Varex Imaging 2.55% 9.19% 4.13% Pro-Dex 17.62% 25.13% 16.02%

Does the media favor VREX or PDEX?

In the previous week, Varex Imaging had 3 more articles in the media than Pro-Dex. MarketBeat recorded 5 mentions for Varex Imaging and 2 mentions for Pro-Dex. Varex Imaging's average media sentiment score of 1.18 beat Pro-Dex's score of 0.60 indicating that Varex Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Varex Imaging 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pro-Dex 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Pro-Dex (PDEX) Competitors

$68.82 -1.21 (-1.72%)

As of 01:01 PM Eastern

Compare

PDEX vs. INMD, SIBN, NNNN, AVR, and VREX

Should you buy Pro-Dex stock or one of its competitors? Pro-Dex's main competitors and comparable companies include InMode (INMD), SiBone (SIBN), Anbio Biotechnology (NNNN), Anteris Technologies Global (AVR), and Varex Imaging (VREX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Pro-Dex compare to InMode?

Pro-Dex (NASDAQ:PDEX) and InMode (NASDAQ:INMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings.

InMode has a net margin of 20.69% compared to Pro-Dex's net margin of 17.62%. Pro-Dex's return on equity of 25.13% beat InMode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	17.62%	25.13%	16.02%
InMode	20.69%	11.99%	10.60%

InMode has higher revenue and earnings than Pro-Dex. InMode is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$77.55M	2.84	$13.66M	$4.13	16.66
InMode	$374.63M	2.17	$93.83M	$1.23	11.52

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by company insiders. Comparatively, 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Pro-Dex has a beta of 0.06, indicating that its share price is 94% less volatile than the broader market. Comparatively, InMode has a beta of 1.86, indicating that its share price is 86% more volatile than the broader market.

In the previous week, InMode had 1 more articles in the media than Pro-Dex. MarketBeat recorded 3 mentions for InMode and 2 mentions for Pro-Dex. InMode's average media sentiment score of 0.89 beat Pro-Dex's score of 0.60 indicating that InMode is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pro-Dex	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InMode	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Pro-Dex currently has a consensus target price of $74.00, suggesting a potential upside of 7.53%. InMode has a consensus target price of $16.00, suggesting a potential upside of 12.95%. Given InMode's higher possible upside, analysts plainly believe InMode is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
InMode	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Pro-Dex and InMode tied by winning 8 of the 16 factors compared between the two stocks.

How does Pro-Dex compare to SiBone?

Pro-Dex (NASDAQ:PDEX) and SiBone (NASDAQ:SIBN) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation and institutional ownership.

Pro-Dex has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$77.55M	2.84	$13.66M	$4.13	16.66
SiBone	$213.60M	3.94	-$18.90M	-$0.34	N/A

Pro-Dex presently has a consensus target price of $74.00, suggesting a potential upside of 7.53%. SiBone has a consensus target price of $24.17, suggesting a potential upside of 27.33%. Given SiBone's higher probable upside, analysts clearly believe SiBone is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

Pro-Dex has a net margin of 17.62% compared to SiBone's net margin of -6.85%. Pro-Dex's return on equity of 25.13% beat SiBone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	17.62%	25.13%	16.02%
SiBone	-6.85%	-8.23%	-6.07%

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 98.1% of SiBone shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by insiders. Comparatively, 4.0% of SiBone shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Pro-Dex has a beta of 0.06, suggesting that its stock price is 94% less volatile than the broader market. Comparatively, SiBone has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market.

In the previous week, SiBone had 4 more articles in the media than Pro-Dex. MarketBeat recorded 6 mentions for SiBone and 2 mentions for Pro-Dex. SiBone's average media sentiment score of 0.81 beat Pro-Dex's score of 0.60 indicating that SiBone is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pro-Dex	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SiBone	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Pro-Dex beats SiBone on 9 of the 17 factors compared between the two stocks.

How does Pro-Dex compare to Anbio Biotechnology?

Pro-Dex (NASDAQ:PDEX) and Anbio Biotechnology (NASDAQ:NNNN) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

Pro-Dex has higher revenue and earnings than Anbio Biotechnology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$77.55M	2.84	$13.66M	$4.13	16.66
Anbio Biotechnology	$8.65M	103.69	$6.40M	N/A	N/A

Pro-Dex has a beta of 0.06, meaning that its share price is 94% less volatile than the broader market. Comparatively, Anbio Biotechnology has a beta of 5.17, meaning that its share price is 417% more volatile than the broader market.

In the previous week, Pro-Dex had 1 more articles in the media than Anbio Biotechnology. MarketBeat recorded 2 mentions for Pro-Dex and 1 mentions for Anbio Biotechnology. Anbio Biotechnology's average media sentiment score of 1.79 beat Pro-Dex's score of 0.60 indicating that Anbio Biotechnology is being referred to more favorably in the news media.

Company	Overall Sentiment
Pro-Dex	Positive
Anbio Biotechnology	Very Positive

Pro-Dex presently has a consensus target price of $74.00, suggesting a potential upside of 7.53%. Given Pro-Dex's stronger consensus rating and higher possible upside, equities analysts clearly believe Pro-Dex is more favorable than Anbio Biotechnology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
Anbio Biotechnology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

15.3% of Pro-Dex shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Pro-Dex has a net margin of 17.62% compared to Anbio Biotechnology's net margin of 0.00%. Pro-Dex's return on equity of 25.13% beat Anbio Biotechnology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	17.62%	25.13%	16.02%
Anbio Biotechnology	N/A	N/A	N/A

Summary

Pro-Dex beats Anbio Biotechnology on 12 of the 15 factors compared between the two stocks.

How does Pro-Dex compare to Anteris Technologies Global?

Anteris Technologies Global (NASDAQ:AVR) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

Anteris Technologies Global has a beta of 1.8, suggesting that its share price is 80% more volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.06, suggesting that its share price is 94% less volatile than the broader market.

15.3% of Pro-Dex shares are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by company insiders. Comparatively, 45.9% of Pro-Dex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Pro-Dex has a net margin of 17.62% compared to Anteris Technologies Global's net margin of -4,619.27%. Pro-Dex's return on equity of 25.13% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-4,619.27%	-77.69%	-67.99%
Pro-Dex	17.62%	25.13%	16.02%

Pro-Dex has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	397.49	-$94.14M	-$1.95	N/A
Pro-Dex	$77.55M	2.84	$13.66M	$4.13	16.66

Anteris Technologies Global currently has a consensus price target of $16.00, indicating a potential upside of 105.39%. Pro-Dex has a consensus price target of $74.00, indicating a potential upside of 7.53%. Given Anteris Technologies Global's higher possible upside, research analysts clearly believe Anteris Technologies Global is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

In the previous week, Anteris Technologies Global had 2 more articles in the media than Pro-Dex. MarketBeat recorded 4 mentions for Anteris Technologies Global and 2 mentions for Pro-Dex. Anteris Technologies Global's average media sentiment score of 0.83 beat Pro-Dex's score of 0.60 indicating that Anteris Technologies Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pro-Dex	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Pro-Dex beats Anteris Technologies Global on 11 of the 17 factors compared between the two stocks.

How does Pro-Dex compare to Varex Imaging?

Varex Imaging (NASDAQ:VREX) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

Pro-Dex has lower revenue, but higher earnings than Varex Imaging. Pro-Dex is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Varex Imaging	$865M	0.90	-$70.30M	$0.52	35.51
Pro-Dex	$77.55M	2.84	$13.66M	$4.13	16.66

Pro-Dex has a net margin of 17.62% compared to Varex Imaging's net margin of 2.55%. Pro-Dex's return on equity of 25.13% beat Varex Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Varex Imaging	2.55%	9.19%	4.13%
Pro-Dex	17.62%	25.13%	16.02%

Varex Imaging currently has a consensus price target of $16.88, indicating a potential downside of 8.61%. Pro-Dex has a consensus price target of $74.00, indicating a potential upside of 7.53%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts plainly believe Pro-Dex is more favorable than Varex Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Varex Imaging	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

15.3% of Pro-Dex shares are held by institutional investors. 4.6% of Varex Imaging shares are held by insiders. Comparatively, 45.9% of Pro-Dex shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Varex Imaging had 3 more articles in the media than Pro-Dex. MarketBeat recorded 5 mentions for Varex Imaging and 2 mentions for Pro-Dex. Varex Imaging's average media sentiment score of 1.18 beat Pro-Dex's score of 0.60 indicating that Varex Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Varex Imaging	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pro-Dex	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Varex Imaging has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.06, meaning that its share price is 94% less volatile than the broader market.

Summary

Pro-Dex beats Varex Imaging on 12 of the 17 factors compared between the two stocks.

Get Pro-Dex News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PDEX vs. The Competition

Export

Metric	Pro-Dex	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$220.21M	$5.41B	$7.26B	$13.17B
Dividend Yield	N/A	1.79%	2.52%	14.19%
P/E Ratio	16.66	25.07	274.41	25.76
Price / Sales	2.84	68.49	659.61	91.46
Price / Cash	18.35	32.94	80.06	52.35
Price / Book	4.61	5.68	10.43	6.35
Net Income	$13.66M	$149.51M	$3.50B	$360.42M
7 Day Performance	-4.34%	-2.01%	-1.17%	-1.50%
1 Month Performance	10.00%	-5.62%	-4.03%	-4.03%
1 Year Performance	103.29%	5.30%	12.93%	3.96%

Pro-Dex Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PDEX Pro-Dex	2.9715 of 5 stars	$68.82 -1.7%	$74.00 +7.5%	+106.5%	$220.21M	$77.55M	16.66	206
INMD InMode	1.9442 of 5 stars	$14.45 -0.3%	$16.00 +10.7%	-5.2%	$833.47M	$370.49M	11.75	660
SIBN SiBone	2.4295 of 5 stars	$18.81 +2.0%	$24.17 +28.5%	+35.1%	$818.24M	$200.93M	N/A	376	Positive News
NNNN Anbio Biotechnology	0.9453 of 5 stars	$5.58 -1.8%	N/A	N/A	$817.30M	$8.65M	N/A	27	Positive News
AVR Anteris Technologies Global	2.605 of 5 stars	$8.13 -0.2%	$16.00 +96.8%	+74.1%	$794.29M	$1.91M	N/A	174

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PDEX) was last updated on 9/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Pro-Dex (PDEX) Competitors

PDEX vs. INMD, SIBN, NNNN, AVR, and VREX

How does Pro-Dex compare to InMode?

Summary

How does Pro-Dex compare to SiBone?

Summary

How does Pro-Dex compare to Anbio Biotechnology?

Summary

How does Pro-Dex compare to Anteris Technologies Global?

Summary

How does Pro-Dex compare to Varex Imaging?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PDEX vs. The Competition

Pro-Dex Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Pro-Dex (PDEX) Competitors

PDEX vs. INMD, SIBN, NNNN, AVR, and VREX

How does Pro-Dex compare to InMode?

Is PDEX or INMD more profitable?

Which has better earnings and valuation, PDEX or INMD?

Do institutionals & insiders hold more shares of PDEX or INMD?

Which has more risk and volatility, PDEX or INMD?

Does the media refer more to PDEX or INMD?

Do analysts recommend PDEX or INMD?

Summary

How does Pro-Dex compare to SiBone?

Which has higher valuation & earnings, PDEX or SIBN?

Do analysts rate PDEX or SIBN?

Is PDEX or SIBN more profitable?

Do institutionals & insiders hold more shares of PDEX or SIBN?

Which has more volatility and risk, PDEX or SIBN?

Does the media prefer PDEX or SIBN?

Summary

How does Pro-Dex compare to Anbio Biotechnology?

Which has stronger valuation and earnings, PDEX or NNNN?

Which has more risk and volatility, PDEX or NNNN?

Does the media prefer PDEX or NNNN?

Do analysts recommend PDEX or NNNN?

Do insiders and institutionals hold more shares of PDEX or NNNN?

Is PDEX or NNNN more profitable?

Summary

How does Pro-Dex compare to Anteris Technologies Global?

Which has more risk and volatility, AVR or PDEX?

Do insiders & institutionals have more ownership in AVR or PDEX?

Is AVR or PDEX more profitable?

Which has higher valuation & earnings, AVR or PDEX?

Do analysts prefer AVR or PDEX?

Does the media favor AVR or PDEX?

Summary

How does Pro-Dex compare to Varex Imaging?

Which has preferable earnings & valuation, VREX or PDEX?

Is VREX or PDEX more profitable?

Do analysts recommend VREX or PDEX?

Do insiders and institutionals believe in VREX or PDEX?

Does the media favor VREX or PDEX?

Which has more volatility & risk, VREX or PDEX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PDEX vs. The Competition

Pro-Dex Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools